GE HealthCare
GEHC
Market cap $32.8B

71.64 USD

-6.08

7.82%

At close Jul 30, 4:00 PM EDT

After hours

71.02

-0.62

0.87%

1 day

-7.82%

5 days

-6.96%

1 month

-3.28%

3 months

1.86%

6 months

-20.00%

Year to date

-8.60%

1 year

-13.32%

5 years

19.40%

10 years

19.40%

About: GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Employees: 53,000

Healthcare Health Information Services

0

Funds holding %

of 7,323 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

83% more call options, than puts

Call options by funds: $449M | Put options by funds: $245M

70% more first-time investments, than exits

New positions opened: 160 | Existing positions closed: 94

29% more funds holding in top 10

Funds holding in top 10: 7 [Q4 2024] → 9 (+2) [Q1 2025]

3% more funds holding

Funds holding: 1,298 [Q4 2024] → 1,337 (+39) [Q1 2025]

10% more repeat investments, than reductions

Existing positions increased: 488 | Existing positions reduced: 445

0% less capital invested

Capital invested by funds: $30.3B [Q4 2024] → $30.2B (-$86.2M) [Q1 2025]

2.82% less ownership

Funds ownership: 84.66% [Q4 2024] → 81.84% (-2.82%) [Q1 2025]

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$73

2%

upside

Avg. target

$83

15%

upside

High target

$89

24%

upside

6 analyst ratings

4 positive

67%

2 neutral

33%

0 negative

0%

Citigroup Joanne Wuensch	24%upside $89	Buy Maintained	9 Jul 2025
Morgan Stanley Patrick Wood	9%upside $78	Equal-Weight Maintained	6 May 2025
UBS Graham Doyle	2%upside $73	Neutral Upgraded	5 May 2025
Goldman Sachs David Roman	14%upside $82	Buy Maintained	1 May 2025
Wells Fargo Larry Biegelsen	24%upside $89	Overweight Maintained	1 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 16 articles about GEHC published over the past 30 days

Zacks Investment Research

GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises

GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.

GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises

GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP & CFO Peter J.

GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript

Zacks Investment Research

Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics

GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact

GE HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year.

GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact

Zacks Investment Research

GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1 per share a year ago.

GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates

GE HealthCare raises annual profit forecast on smaller tariff impact

GE HealthCare Technologies raised annual profit forecast on Wednesday, as the medical device maker expects a smaller hit from tariffs.

GE HealthCare raises annual profit forecast on smaller tariff impact

GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.

Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.

GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.

GE HealthCare reports second quarter 2025 financial results

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment. We also reported strong earnings performance while leveraging our lean capabilities and demonstrating progress on tariff mitigation. Overall, we believe.

GE HealthCare reports second quarter 2025 financial results

Zacks Investment Research

Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?

GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.

Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?

GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high-image quality and optimize efficiency in highly demanding environments while enhancing access and affordability. X-ray exams often serve as the entry point to diagnostic imaging, accounting for 60% of all imaging studies conducted, resulting in an ever-increasing workload for radiologists and techno.

GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings

See News Rankings

Charts implemented using Lightweight Charts™